Regulatory classification is the process by which medical devices are assigned to a risk-based class that determines the level of regulatory control, evidence, and oversight required prior to market entry. Classification frameworks exist in all major jurisdictions and are designed to ensure that the level of regulatory scrutiny matches the potential risk to patients and users. Higher-risk devices require more rigorous evidence, conformity assessment, and regulatory review than lower-risk devices.
Risk-based
FDA / EU MDR / IVDR
Global alignment (IMDRF)
FDA / EU MDR / IVDR
Global alignment (IMDRF)
Regulatory classification frameworks
- United States (FDA): Devices are classified into Class I (low risk), Class II (moderate risk), or Class III (high risk) under the FD&C Act. See 21 CFR Parts 862–892 for device-specific classifications.
- European Union (MDR 2017/745): Devices are classified into Class I, IIa, IIb, and III using the rules in Annex VIII. In vitro diagnostics are classified separately under the IVDR (2017/746) into Classes A, B, C, and D.
- Other markets: Many regulators (e.g., Health Canada, TGA Australia, PMDA Japan, Brazil ANVISA, Malaysia MDA) adopt similar risk-based frameworks, often aligned with IMDRF classification principles.
Why classification matters
- Determines evidence requirements: Higher-risk devices (e.g., Class III or Class D) typically require clinical investigation data; lower-risk devices may rely on literature, standards, or bench testing.
- Defines conformity assessment path: In the EU, most Class IIa, IIb, and III devices require Notified Body involvement. In the U.S., Class II typically follows the 510(k) process, while Class III requires PMA.
- Impacts labeling and post-market duties: Higher classes have stricter post-market surveillance (PMS), PMCF/PSUR reporting, and vigilance obligations.
- Global strategy alignment: Early classification is critical to regulatory planning, reimbursement, and go-to-market strategy.
Regulatory Classification — FAQs
What is the lowest-risk medical device class?
In the U.S., Class I devices are generally considered lowest risk and often exempt from premarket review. In the EU MDR, Class I is lowest risk, with some subclasses requiring Notified Body oversight (e.g., sterile or measuring devices).
How does FDA Class II compare to EU Class IIa/IIb?
FDA Class II covers a broad range of moderate-risk devices. EU MDR distinguishes between Class IIa (lower-moderate risk) and Class IIb (higher-moderate risk), requiring different conformity assessment modules.
What are the highest-risk categories?
FDA Class III and EU MDR Class III devices pose the greatest risk (e.g., implants, life-supporting, or high-risk active devices). For IVDs, Class D under IVDR represents the highest risk.
Can classification differ across jurisdictions?
Yes. The same device may be classified differently by FDA, EU MDR, Health Canada, or other regulators. Manufacturers must assess classification rules in each jurisdiction as part of regulatory strategy.
Is classification permanent?
Not always. Classifications can change through rulemaking, reclassification petitions, or regulatory updates. For example, FDA occasionally reclassifies devices based on new safety/effectiveness data.
Regulatory Classification — at a glance
| Framework | Classes | Risk Basis | Typical Pathway / Assessment | Notes |
|---|---|---|---|---|
| U.S. (FDA) | Class I • Class II • Class III | Intended use, indications, and level of control needed to assure safety & effectiveness | Class I: many exempt; Class II: 510(k); Class III: PMA. Novel low–mod risk: De Novo | Device-specific regs in 21 CFR 862–892; expedited options (Breakthrough, STeP) may apply |
| EU MDR | Class I • IIa • IIb • III | Rules in Annex VIII (invasiveness, duration, active/implantable, etc.) | Conformity assessment via Notified Body for IIa/IIb/III; Class I (non-sterile/non-measuring) self-declare | GSPRs Annex I; PMS/PMCF and UDI apply; many legacy devices reclassified higher under MDR |
| EU IVDR (IVDs) | Class A • B • C • D | Rules in Annex VIII IVDR (intended purpose, risk to public health/individuals) | Most IVDs require Notified Body; Class A (non-sterile) self-declare; higher classes need performance evaluation & batch/lot oversight (esp. Class D) | Performance evaluation (scientific validity, analytical, clinical); Eudamed/UDI; increased NB involvement vs IVDD |
- Tip: Determine classification early— it drives evidence, clinical, and conformity route.
- Remember: The same device can classify differently across markets; verify rules per jurisdiction.